Article info
PDFColorectal
Review
Anti-Mycobacterium paratuberculosis (MAP) therapy for Crohn’s disease: an overview and update
- Correspondence to Prof Jeremy Sanderson, IBD Centre, Guy's and Saint Thomas' NHS Foundation Trust, London SE1 7EH, UK; jeremy.sanderson{at}kcl.ac.uk
Citation
Anti-Mycobacterium paratuberculosis (MAP) therapy for Crohn’s disease: an overview and update
Publication history
- Received March 16, 2020
- Revised May 28, 2020
- Accepted June 14, 2020
- First published July 28, 2020.
Online issue publication
January 08, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.